Drug Profile
Icomidocholic acid companion diagnostic - Galmed Pharmaceuticals/One Way Liver Genomics
Alternative Names: Aramchol companion diagnostic - Galmed Pharmaceuticals/One Way Liver GenomicsLatest Information Update: 26 Nov 2018
Price :
$50
*
At a glance
- Originator One Way Liver Genomics
- Developer Galmed Pharmaceuticals; One Way Liver Genomics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 26 Nov 2018 No recent reports of development identified for phase-II development in Non-alcoholic steatohepatitis (Diagnosis) in USA, Chile, Colombia, France, Italy, Germany, Israel, Mexico, Peru, Peru, Romania (unspecified route)
- 30 Jun 2016 Galmed Pharmaceuticals signs an optional licensing agreement with Yeda Research and Development for commercialisation of the companion diagnostic tool
- 23 Jul 2015 Galmed Pharmaceuticals and One Way Liver Genomics plan a phase III trial for Non-alcohollic steatohepatitis (Diagnosis) in USA and Europe ,